Access cutting-edge relapsed or refractory b cell acute lymphoblastic leukemia treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this San Antonio location
Preparing your pre-screening questions…
Access relapsed or refractory b cell acute lymphoblastic leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related relapsed or refractory b cell acute lymphoblastic leukemia treatment provided free
Check if you qualify for this relapsed or refractory b cell acute lymphoblastic leukemia clinical trial in San Antonio, TX
No-Cost Study Care
Local to San Antonio
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase 1b/2 study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 in pediatric patients with relapsed or refractory (r/r) B cell acute lymphoblastic leukemia (B ALL) and r/r B cell Non-Hodgkin lymphoma (B NHL).
Sponsor: Autolus Limited
Yes, this clinical trial (NCT06173518) has an active research site in San Antonio, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for relapsed or refractory b cell acute lymphoblastic leukemia treatment options in San Antonio, TX, this clinical trial (NCT06173518) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced relapsed or refractory b cell acute lymphoblastic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all relapsed or refractory b cell acute lymphoblastic leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in San Antonio — not just this study.
Browse Leukemia Trials in San Antonio →